The consortium comprises Neuberger Berman Private Markets, Swedish buyout group EQT, Canada Pension Plan Investment Board and ...

Sanofi moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, ...

The French drugmaker’s announcement of progress on a deal to sell 50% of its subsidiary Opella to Clayton Dubilier & Rice has failed to calm market jitters over its share price ...

PAI partners has submitted an improved bid for Sanofi’s consumer health business, in an attempt to re-enter the race for what ...

A series of tax raids rightly worry buyout shops, but another long-term decision over tech and AI projects should concern ...

The latest senior moves include a former Conservative MP moving into private equity and a new office opening for Coller ...

More than 450 people took part in the 10th Impetus Private Equity triathlon last month. Teams and individuals from the ...

Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company’s consumer health business, Opella, to ...

The sponge may or may not be thrown in – but the appropriateness of a liquidation has never seemed more obvious ...